Question 61

Metoprolol succinate is an extended-release tablet.

Metoprolol succinate is specifically formulated as an extended-release tablet, allowing for a gradual release of the medication over time, which helps in maintaining stable blood levels.

A) Metoprolol tartrate

Metoprolol tartrate is not an extended-release formulation; it is a short-acting version of metoprolol. This means it requires more frequent dosing to maintain therapeutic levels in the bloodstream, unlike the extended-release variant.

B) Hydroxyzine hydrochloride

Hydroxyzine hydrochloride is available as immediate-release formulations and does not have an extended-release version. This limits its duration of action compared to medications specifically designed for extended release.

C) Metoprolol succinate

Metoprolol succinate is indeed an extended-release tablet, which allows it to provide a prolonged effect with once-daily dosing. This formulation is beneficial for patients needing long-term management of conditions such as hypertension or heart failure.

D) Hydroxyzine pamoate

Hydroxyzine pamoate is another formulation of hydroxyzine that is not classified as extended-release. Like hydroxyzine hydrochloride, it is intended for immediate effects rather than prolonged release.

Conclusion

Metoprolol succinate is definitively the correct answer as it is the only option among the choices that represents an extended-release tablet. All other options either consist of immediate-release formulations or do not have an extended-release equivalent, making them less suitable for sustained therapeutic management.